Cancer Screening

Prostate cancer screening could be improved through accounting for genetic factors that cause noncancer-related variations in PSA levels, according to study results presented at American Association for Cancer Research Annual Meeting.

In a Healio video exclusive, Subhankar Chakraborty, MD, PhD, a gastroenterologist at The Ohio State University Wexner Medical Center, outlines a new initiative that aims to cut colorectal cancer screening disparities in half by 2023.

Individuals whose underlying poor health may make them less likely to benefit from lung cancer screening appeared more likely to undergo the scans than those with better health status, according to study results in JAMA Network Open.

Cancer screening remains in need of urgent attention, and online resources may help facilities close gaps and address screenings missed in 2020, according to a prospective quality improvement study published in Cancer.

For National Colorectal Cancer Awareness Month, Healio presents a collection of videos, Q&As and new data that details improved access to CRC care, the importance of early screening, updated guidelines and more.

Healio spoke with Peter J. Mazzone, MD, MPH, director of the Lung Cancer Program and Lung Cancer Screening Program at the Cleveland Clinic Cancer Center Respiratory Institute, about how the 2021 changes to the USPSTF lung cancer screening guidelines have affected the number of patients being screened, improvements in patient outcomes and how specialists should continue to prepare for the effects of the updated guidelines.

Increases in metastatic prostate cancer incidence may be temporally associated with changes in clinical policy following U.S. Preventive Services Task Force recommendations, according to a study in JAMA Network Open.

In patients with inflammatory bowel disease, colonoscopy within 3 years before colorectal cancer diagnosis was linked with early tumor stage detection, while colonoscopy within 1 year reduced overall all-cause mortality, according to data.

An estimated 1 in 7 screen-detected breast cancers in biennially screened women aged 50 to 74 years will be overdiagnosed, according to an analysis of an authoritative U.S. population data set published in Annals of Internal Medicine.

Researchers conducted a study to determine whether commonly used medications influence responses to cancer treatment. They found that antihistamines were associated with improved immunotherapy efficacy.